Drug Discovery - Search News

$Reid Hoffman’s Manas AI raises $24.6M, a fraction of other AI drug discovery startups$

Reid Hoffman’s Manas AI raises $24.6M, a fraction of other AI drug discovery startups

LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an

Observer · 3d

Reid Hoffman Bets on A.I. Drug Discovery with a Pulitzer-Winning Cancer Physician

Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is expected to generate between $60 billion and $110 billion annually in value for the pharmaceutical and medical-product industries, according to a McKinsey report released last year.

The Wall Street Journal on MSN · 4d

Reid Hoffman Raises $24.6 Million for AI Cancer Research Startup

Tech investor and LinkedIn co-founder Reid Hoffman is teaming up with cancer researcher Siddhartha Mukherjee on an artificial intelligence drug discovery startup that is launching with $24.6 million of initial funding.

Nature18h

US drug agency approves potent painkiller — the first non-opioid in decades

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

technologynetworks18h

Improving Efficiency in Drug Discovery and Development

This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing processes and exploring innovations that could streamline the path from ...

devdiscourse2d

Rethinking AI hallucinations: Unlocking new frontiers in drug discovery

Hallucinations in LLMs refer to instances where models generate plausible yet incorrect or unrelated information.

The University of Chicago Chronicle2d

Collaboration to provide up to $130 million to fuel drug discovery, development at UChicago

Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...

GlobalData on MSN1d

Acellera and Psivant partner for AI-driven drug discovery

Acellera Therapeutics focuses on drug discovery by merging AI-driven innovation with computational scaleability, aiming to ...

News Medical on MSN2d

Schrödinger selects Sapio Sciences to enhance in silico drug discovery from plasmid to structure

Sapio Sciences, the science-aware™ lab informatics platform, today announced that Schrödinger, a global leader in computational chemistry, has adopted the Sapio Platform to improve data management, ...

The Next Web10d

Europe accelerates AI drug discovery as DeepMind spinoff targets trials this year

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

7don MSN

Recursion Pharmaceuticals (RXRX): Industrializing Drug Discovery with AI Amid J.P. Morgan’s ‘Neutral’ Outlook

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Manas AI Launches to Transform Discovery of Novel Cancer Medicines

Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its ...

ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, ...

technologynetworks2d

The Future of Machine Learning in Drug Discovery

This webinar explores the current state and potential of machine learning in drug discovery, providing clarity amidst the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results